Schedule 13D ownership disclosure

RANI THERAPEUTICS HLDGS INC

Class A Common Stock, par value $0.0001 per share · CUSIP: 753018100

Event date: 2025-10-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • South Cone Investments Limited PartnershipReported CIK 0001876412

    Shares: 2,379,194.00 · Class: 4.9%

  • South Lake One LLCReported CIK 0001794292

    Shares: 2,379,194.00 · Class: 4.9%

  • South Lake Management LLC

    Shares: 2,379,194.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-101616
Form type
SCHEDULE 13D/A
Filer
Rani Therapeutics Holdings, Inc.
CIK
CIK 1856725
Filed
Oct 22, 2025
Reporting period
Oct 20, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub